These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 20482780)
1. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis. Woo JM; Lin Z; Navab M; Van Dyck C; Trejo-Lopez Y; Woo KM; Li H; Castellani LW; Wang X; Iikuni N; Rullo OJ; Wu H; La Cava A; Fogelman AM; Lusis AJ; Tsao BP Arthritis Res Ther; 2010; 12(3):R93. PubMed ID: 20482780 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST Diabetes; 2010 Dec; 59(12):3223-8. PubMed ID: 20826564 [TBL] [Abstract][Full Text] [Related]
3. ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. Feng X; Li H; Rumbin AA; Wang X; La Cava A; Brechtelsbauer K; Castellani LW; Witztum JL; Lusis AJ; Tsao BP J Lipid Res; 2007 Apr; 48(4):794-805. PubMed ID: 17259598 [TBL] [Abstract][Full Text] [Related]
4. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. Navab M; Ruchala P; Waring AJ; Lehrer RI; Hama S; Hough G; Palgunachari MN; Anantharamaiah GM; Fogelman AM J Lipid Res; 2009 Aug; 50(8):1538-47. PubMed ID: 19225094 [TBL] [Abstract][Full Text] [Related]
6. Endothelial cell injury is involved in atherosclerosis and lupus symptoms in gld.apoE Yao G; Qi J; Zhang Z; Huang S; Geng L; Li W; Chen W; Tang X; Wang S; Sun L Int J Rheum Dis; 2019 Mar; 22(3):488-496. PubMed ID: 30575313 [TBL] [Abstract][Full Text] [Related]
8. Atherosclerotic plaque vulnerability is increased in mouse model of lupus. Santiago-Raber ML; Montecucco F; Vuilleumier N; Miteva K; Baptista D; Carbone F; Pagano S; Roth A; Burger F; Mach F; Brandt KJ Sci Rep; 2020 Oct; 10(1):18324. PubMed ID: 33110193 [TBL] [Abstract][Full Text] [Related]
9. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice. Zhang X; Xiao S; Li Q J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421 [TBL] [Abstract][Full Text] [Related]
10. Induced carotid atherosclerosis in lupus mice. Wang Y; Huang Z; Lin L; Huang G; Liu W; Xue Y Clin Exp Hypertens; 2019; 41(5):492-497. PubMed ID: 30235005 [TBL] [Abstract][Full Text] [Related]
11. Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6C Chen Y; Zhang H; Hu L; Shi H; Liu X; Jia J; Sun S; Ou Y; Luo X; Zhou G; Shen W J Int Med Res; 2020 Jul; 48(7):300060520932816. PubMed ID: 32662710 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice. Park KY; Heo TH Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752 [TBL] [Abstract][Full Text] [Related]
13. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice. Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice. Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190 [TBL] [Abstract][Full Text] [Related]
15. Accelerated atherosclerosis in ApoE deficient lupus mouse models. Ma Z; Choudhury A; Kang SA; Monestier M; Cohen PL; Eisenberg RA Clin Immunol; 2008 May; 127(2):168-75. PubMed ID: 18325838 [TBL] [Abstract][Full Text] [Related]
16. Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway. Yan W; Li D; Zhou X Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):344-352. PubMed ID: 27998006 [TBL] [Abstract][Full Text] [Related]
17. Pravastatin attenuates interferon-gamma action via modulation of STAT1 to prevent aortic atherosclerosis in apolipoprotein E-knockout mice. Zhou XX; Gao PJ; Sun BG Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):373-9. PubMed ID: 19018808 [TBL] [Abstract][Full Text] [Related]
18. Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis. Mendez-Fernandez Y; Major A Arthritis Res Ther; 2010; 12(5):139. PubMed ID: 20854650 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Sherman CB; Peterson SJ; Frishman WH Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E-knockout mice on high-fat diet show autoimmune injury on kidney and aorta. Wang Y; Lu H; Huang Z; Lin H; Lei Z; Chen X; Tang M; Gao F; Dong M; Li R; Lin L Biochem Biophys Res Commun; 2014 Jul; 450(1):788-93. PubMed ID: 24953693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]